By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it demonstrated that VXX-401 lowers LDL cholesterol, supporting its potential for treating hypercholesterolemia. The VXX-401, a synthetic peptide vaccine, aims to provide a safe and effective solution against heart disease by targeting PCSK9, the company said in a statement. The studies were published in the Journal of […]
Vaxxinity, Inc. (NASDAQ:VAXX – Get Free Report)’s stock price fell 2.2% on Wednesday . The stock traded as low as $0.70 and last traded at $0.70. 463,479 shares changed hands during trading, an increase of 162% from the average session volume of 176,564 shares. The stock had previously closed at $0.72. Vaxxinity Price Performance The […]
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it’s with the University of Florida’s Center for Translational Research in Neurodegenerative Disease (CTRND) to develop vaccines for diseases like Alzheimer’s and Parkinson’s. The collaboration aims to understand and neutralize toxic brain proteins, Vaxxinity said. UF researchers will conduct preclinical studies to evaluate candidates and potentially offer […]